iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Aurobindo Pharma Faces Share Price Dip as USFDA Issues 10 Observations to Subsidiary

26 Dec 2023 , 02:47 PM

Aurobindo Pharma’s share price declined in the opening trade on December 26 due to 10 observations from the USFDA received by its subsidiary. At 9:31 am, Aurobindo Pharma was quoted at Rs 1,060.00 on the BSE, marking a 0.58 % decrease. At the time of writing, the stock was trading at Rs 1059 making a 0.68% dip.

The USFDA conducted a pre-approval inspection at Eugia US Manufacturing LLC, Aurobindo Pharma’s subsidiary in New Jersey.

The inspection period was from December 11 to 22, 2023, resulting in 10 procedural observations. Responses to the observations will be provided within the stipulated time, and the plant is yet to begin commercial operations.

Last week, the USFDA classified a plant operated by Aurobindo Pharma’s subsidiary, APL Healthcare in Tirupati, as ‘Voluntary Action Indicated.’

This classification, based on identified deficiencies during inspection, does not warrant official regulatory action. The inspection took place at Unit IV of APL Healthcare Limited in Tirupati, Andhra Pradesh.

Aurobindo Pharma reported an 85 % YoY rise in consolidated net profit to Rs 757 crore for the July-September quarter of the current financial year.

For feedback and suggestions, write to us at editorial@iifl.com
 

Related Tags

  • Aurobindo Pharma
  • news
  • stocks
  • USFDA
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.